Knowledge Gaps in Treatment and Biomarkers for Melanoma Differentiation-Associated Gene 5 Dermatomyositis With Rapidly Progressive Interstitial Lung Disease

被引:0
|
作者
Nikolic, Roko [1 ]
Krustev, Eugene [2 ]
Fritzler, Marvin [2 ]
Choi, May [2 ]
Toro, Cristina Moran [2 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada
[2] Univ Calgary, Calgary, AB, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TOUR8C
引用
收藏
页码:35 / 35
页数:1
相关论文
共 50 条
  • [41] Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis
    Matsushita, T.
    Mizumaki, K.
    Kano, M.
    Yagi, N.
    Tennichi, M.
    Takeuchi, A.
    Okamoto, Y.
    Hamaguchi, Y.
    Murakami, A.
    Hasegawa, M.
    Kuwana, M.
    Fujimoto, M.
    Takehara, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (02) : 395 - 402
  • [43] Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease
    Xu, Lingxiao
    You, Hanxiao
    Wang, Lei
    Lv, Chengyin
    Yuan, Fenghong
    Li, Ju
    Wu, Min
    Da, Zhanyun
    Wei, Hua
    Yan, Wei
    Zhou, Lei
    Yin, Songlou
    Zhou, Dongmei
    Wu, Jian
    Lu, Yan
    Su, Dinglei
    Liu, Zhichun
    Liu, Lin
    Ma, Longxin
    Xu, Xiaoyan
    Zang, Yinshan
    Liu, Huijie
    Ren, Tianli
    Wang, Fang
    Du, Yan
    Xue, Jing
    Zhang, Miaojia
    Tan, Wenfeng
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (04) : 609 - 619
  • [44] Interstitial lung disease based on autoimmunity against melanoma differentiation-associated gene 5
    Ichimura, Y.
    Konishi, R.
    Nomura, T.
    Fujimoto, M.
    Okiyama, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S5 - S5
  • [45] Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
    Li, Xiaomeng
    Liu, Yongmei
    Cheng, Linlin
    Huang, Yuan
    Yan, Songxin
    Li, Haolong
    Zhan, Haoting
    Li, Yongzhe
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)
  • [46] The Clinical Features of Recurrent Interstitial Lung Disease in Dermatomyositis Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody
    Hosono, Yuji
    Nakashima, Ran
    Murakami, Kosaku
    Imura, Yoshitaka
    Yukawa, Naoichiro
    Yoshifuji, Hajime
    Ohmura, Koichiro
    Mimori, Tsuneyo
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [47] Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
    Isono, Taisuke
    Nakajima, Hiromi
    Takano, Kenji
    Kobayashi, Yoichi
    Kawabata, Yoshinori
    Shimizu, Yoshihiko
    Takayanagi, Noboru
    RESPIRATORY MEDICINE CASE REPORTS, 2021, 34
  • [48] Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review
    He, Chenjia
    Li, Wenyu
    Xie, Qibing
    Yin, Geng
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [49] Anti-melanoma differentiation-associated protein 5 autoantibodies as a marker for dermatomyositis-associated interstitial lung disease
    Jordan, M.
    Ghoreschi, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (02) : 294 - 295
  • [50] Successful Treatment Of Rapidly Progressive Interstitial Lung Disease Due To Melanoma Differentiation Associated Gene 5 (mda5) Antibody Associated Clinically Amyopathic Dermatomyositis With Cyclophosphamide And Intravenous Immunoglobulin
    Reagle, Z.
    Andrews, S.
    DeJesus, E.
    Yuvienco, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191